437 results on '"Zhuravleva M."'
Search Results
2. Editorial Conference Comments by the Editors
3. Gamma-ray spectroscopic characterization of long, rapidly-grown KSr2I5:Eu crystals
4. Observations regarding inclusions in the growth of Cs2HfCl6 single crystal scintillators
5. Pharmacoeconomic analysis of using empegfilgrastim for the treatment of early and locally advanced HER2+ breast cancer in the Russian Federation
6. A clinical case of post-concussion syndrome in an elite professional football player
7. Cost-effectiveness of valsartan+sakubitril, dapagliflosin and empagliflosin for prevention of cardiovascular death and reducing cardiovascular mortality within the State Program "Health Development" in patients with heart failure
8. The Effect of I155T, K156Q, K156E and N186K Mutations in Hemagglutinin on the Virulence and Reproduction of Influenza A/H5N1 Viruses
9. Conference Comments
10. Crystal growth and characterization of high performance KSr2BrxI5−x:Eu scintillators
11. Characterization of mixed halide scintillators: CsSrBrI2:Eu, CsCaBrI2:Eu and CsSrClBr2:Eu
12. The study of acute and subchronic oral toxicity of medicinal drug «Enrocolitrim» on laboratory animals
13. Retrospective pharmacoeconomic study of antibiotic therapy in community-acquired pneumonia
14. Timing limits of ultrafast cross-luminescence emission in CsZnCl-based crystals for TOF-PET, HEP and TOF-CT
15. Development of Novel CsCl-based Ultrafast Scintillators
16. Clinical Pharmacology of Antimicrobials: Focus on the Safety of Vancomycin and Linezolid
17. 88P Evaluating the infiltration of anti-NKG2DL CAR-T cells into a 3D cell culture developed in a Vitvo cartridge bioreactor
18. Review of pharmacoeconomic studies of melanoma treatment for the period 2018–2023
19. Crystal Growth and Scintillation Properties of Eu2+ doped Cs4CaI6 and Cs4SrI6
20. Exploring growth conditions and Eu2+ concentration effects for KSr2I5:Eu scintillator crystals II: Ø 25 mm crystals
21. Controversial Points in the Assessment of the Quality of Generic Esomeprazole Formulations
22. Economic aspects of the fixed combinations of lipid lowering medicines in group risks patients
23. Pharmacoeconomic analysis of tixagevimab and cilgavimab combination for COVID-19 therapy
24. Development of methodological approaches to the formation of a risk-based model to minimize the prevalence of adverse reactions in drug application in medical organizations of Moscow
25. New high performing scintillators: RbSr2Br5:Eu and RbSr2I5:Eu
26. Tuning the structure of CsCaI3:Eu via substitution of bromine for iodine
27. Antioxidant enzymes and reactive oxygen species level of the Achromobacter xylosoxidans bacteria during hydrocarbons biotransformation
28. Hydroisomerization of Benzene-Containing Gasoline Fraction on Pt/B2O3–Al2O3 and Pt/WO3–Al2O3 Catalysts
29. Clostridioides difficile infection: diagnosis, treatment, and prevention Clinical guidelines of the Russian Scientific Medical Society of Internal Medicine, the Gastroenterological Scientific Society of Russia, and the North- West Society of Gastroenterologists and Hepatologists
30. Colonic diverticular disease: clinical presentation, diagnosis, treatment, and prevention Clinical guidelines of the Russian Scientific Medical Society of Internal Medicine, the Gastroenterological Scientific Society of Russia, and the North- West Society of Gastroenterologists and Hepatologists
31. Application of the cost-effectiveness method in improving the pharmacotherapy of multiple myeloma
32. Сost-effectiveness of preventing cardiovascular death and achieving the target indicator "Reduction of the cardiovascular mortality of the population" of the State Program "Health Development" when using valsartan+sacubitril, dapagliflozin and empagliflozin in patients with heart failure with reduced ejection fraction
33. Scintillation properties of Eu2+-doped KBa2I5 and K2BaI4
34. Retrospective Analysis of the Safety of Antibacterial Medicinal Products for Elderly Patients with Community-Acquired Lower Respiratory Tract Infections
35. Crystal growth and scintillation properties of potassium strontium bromide
36. Crystal structure and thermal expansion of a CsCe2Cl7 scintillator
37. Growth and characterization of potassium strontium iodide: A new high light yield scintillator with 2.4% energy resolution
38. Retrospective Analysis of the Initial Empirical Antibiotic Therapy Effectiveness for Community-Acquired Pneumonia in Young Individuals in Moscow Multidisciplinary Hospital
39. FEATURES OF THE USE OF ANTIBACTERIAL DRUGS IN PATIENTS WITH COVID-19
40. Recombinant Plasmid DNA Construct Encoding Combination of vegf165 and bmp2 cDNAs Stimulates Osteogenesis and Angiogenesis In Vitro
41. Generation of Plasmid DNA Expressing Species-Specific Horse VEGF164 and FGF2 Factors for Gene Therapy
42. Endocrine disorders associated with COVID 19. Adrenal insufficiency
43. Assessment of The Toxicological Profile of The New Dioxidine Dosage Form (Solution for Topical and External Use, 0.025%)
44. SYNERGIC EFFECT OF PREPARATION WITH COORDINATION COMPLEX “TRIMETHYDRAZINIUM PROPIONATE+ETHYMTH METHYLHYDROXYPIRIDINE SUCCINATE” ON ENERGY METABOLISM AND CELL RESPIRATION
45. Aspects of the Safe Use of Antibacterial Drugs in Community-Acquired Pneumonia: the Implications of Drug-Drug Interactions
46. Pharmacoeconomic analysis of using benralizumab for treatment of severe asthma in inpatient and outpatient settings
47. Comparative Dissolution Kinetics of Several Multisource Thioctic Acid Products
48. Evaluation of the Efficacy and Safety of Initial Empirical Antibiotic Therapy for Community-Acquired Pneumonia in Middle-Aged People
49. Evaluation of the Effect of Comorbidity on the Efficacy and Safety of β-Lactam Antibiotics in Patients with Community-Acquired Pneumonia
50. Assessment of Safety Signals for Aztreonam in Different Age Groups: National and International Drug Safety Monitoring
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.